期刊文献+

糖肾通络方对早期糖尿病肾病患者血清内皮素、心钠素的影响 被引量:2

Effect of Tangshen Tongluo Recipe on Serum ET and ANP in Patients with Early Diabetic Nephropathy
暂未订购
导出
摘要 目的探讨糖肾通络方治疗糖尿病肾病(DN)的疗效及机理。方法45例DN患者随机分为糖肾通络方组(25例)及络丁新组(20例),采用中医证候积分法观察2组治疗前后的积分,采用放射免疫法检测2组治疗前后血中的内皮素(ET)、心钠素(ANP)含量,采用生化法检测血中空腹血糖(FBG)、糖化血红蛋白(HbA1c)、胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)含量及尿蛋白排泄率(UAER)。结果2组治疗后中医证候积分糖肾通络方组明显低于络丁新组(P<0.01),临床总有效率糖肾通络方组明显优于络丁新组(P<0.05),虽然2组患者血中ET、ANP和FBG、HbA1c及UAER均较治疗前明显下降(P<0.05,P<0.01),但糖肾通络方组下降明显优于络丁新组(P<0.05,P<0.01),治疗后糖肾通络方组的TC、TG、LDL-C下降,HDL-C升高较络丁新组明显(P<0.05,P<0.01)。结论糖肾通络方具有较好的调整血脂、血糖,尤其是改善全身症状、提高生活质量的作用,并且能够减低或阻止ANP、ET的产生和分泌,改善肾脏受损的微血管,促进肾小球硬化的修复,达到改善肾功能的目的。 Objective To explore effect of the Tangshen Tongluo (TSTL) recipe on ET and ANP in patients with early diabetic nephropathy (DN). Methods 45 Cases of early DN patients were randomly divided into the TSTL recipe group (25 cases) and Lotensin group (20 cases). After the treatment of TSTL recipe and Lotensin, TCM symptom, the level of FBG, HbAlc, ET, ANP, TC, TG, HDL-C, LDL-C and urine micro albumen excretion rate (UAER) were detected. Results After the treatment of TSTL recipe and Lotensin, TCM symptom, the level of FBG, ET, ANP, TC, TG, LDL-C and UAER were found markedly lower in the TSTL recipe than that in the Lotensin group (P 〈0.05, P 〈0.01), and the level of HDL-C was found markedly increased than that in the Lotensin group (P〈0.01). The total effective rate in the TSTL recipe group was 84.00%, which was higher than that in the Lotensin group (50.00%), showing significant difference statistically (P〈0.05). Conclusion TSTL recipe has functions of regulating lipid metabolism and blood glucose, reduce the levels of ET, ANP and UAER, improving main clinical symptoms and quality of life, thus can markedly improve renal function.
出处 《中国中医药信息杂志》 CAS CSCD 2007年第11期13-15,共3页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 糖肾通络方 糖尿病肾病 内皮素 心钠素 尿白蛋白排泄率:肾功能 TangshenTongluo recipe diabetic nephropathy ET ANP UAER renal function
  • 相关文献

参考文献5

二级参考文献19

  • 1冯波,金之欣.Ⅱ型糖尿病患者肾素-血管紧张素系统和激肽-前列腺素-血栓素系统的相互作用研究[J].中国糖尿病杂志,1994,2(1):22-25. 被引量:6
  • 2吕仁和,高彦彬,易京红,胡继玲,王越,冯兴忠,赵进喜,于秀辰,孙军,娄锡恩,杨晓晖,章鸿英,林得玉,范冠杰.止消通脉饮治疗糖尿病微血管病变的临床研究[J].北京中医药大学学报,1996,19(5):25-28. 被引量:20
  • 3王耀献.止消通脉宁治疗糖尿病肾病的实验与临床研究:[学位论文].北京:北京中医药大学,1999.
  • 4孙军.止消通脉宁治疗糖尿病肾病的实验及临床研究:[学位论文].北京:北京中医药大学,1996.
  • 5Simon hi, Rockl W, Hornig C, et al. Receptors of vascular endothelial growth factor/vascular permeability factor(VEGF/VPF) in fetal and adult human kidney; localization and [125I] VEGF binding dites. J Am Soc Nephrol 1998 ;9(10) : 1032.
  • 6Simon M, Grone HJ, Johren O, et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995;268(1) :F240.
  • 7Kim NH, Jung HH, Cha DR, et al. Expression of vacular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol 2000;165(3) :617.
  • 8Cooper ME, Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and VEGFR -2 in experimental diabetes. Diabetes 1999 ;48(11) :2229.
  • 9Pupilli C, Lasagni L, Romagnani P, et al. Angiotensin Ⅱ stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 1999;10(3) :245.
  • 10Ame miya T, Sasamura H, Mifune M, et al. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Kidney Int 1999 ;56(9) :2055.

共引文献63

同被引文献75

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部